Awards:

• 2023 Society for Healthcare Epidemiology of America Mentor-Scholar Career Award at the ID Week 2023, Boston, Massachusetts
• 2021: Medical Society of Virginia Foundation Salute to Service Award- Service for Advancing Patient Safety and Quality Improvement
• 2021: Global Medicine Alumnus of the Year Award. University of Buffalo
• 2020: Richmond Magazine Best Doctors in Richmond- Infectious Diseases
• 2020: VCU Department of Medicine Celebration of Excellence Award for Reseach and Scholarship in Quality and Patient Safety
• 2019: Society for Healthcare Epidemiology of America (SHEA) Barry Farr Award for the most influential publication in infection prevention and hospital epidemiology (2018). Presented at ID Week 2019 Annual Meeting, Washington DC, October 4, 2019.
• 2019: Richmond Magazine Best Doctors in Richmond- Infectious Diseases
• 2016: Fellow of the Infectious Diseases Society of America
• 2015: Richard P. Wenzel Professor of Medicine, Virginia Commonwealth University
• 2014: VCU School of Medicine Educational Innovation Award
• 2014: Visiting Professorship- University at Buffalo School of Medicine and Biomedical Sciences (Infectious Diseases), October 18-21, 2014
• 2014: Fellow of the Society for Healthcare Epidemiology of America (FSHEA)
• 2012-2013 Academic Year: VCU SOM High Evaluation High Evaluation Teaching Award M1 Population Medicine
• 2012-2013 Academic Year: VCU SOM High Evaluation High Evaluation Teaching Award M2 Microbiology Course
• 2013: VCU Medical Center Shining Knight Honor
• 2016: VCU Medical Center Shining Knight Honor
• 2018: Richmond Magazine Best Doctors in Richmond- Infectious Diseases
• 2018: Virginia Living Magazine Top Doctors 2018- Infectious Diseases
• 2017: Richmond Magazine Best Doctors in Richmond- Infectious Diseases
• 2016: Richmond Magazine Best Doctors in Richmond- Infectious Diseases
• 2015: Richmond Magazine Best Doctors in Richmond- Infectious Diseases
• 2014: Richmond Magazine Best Doctors in Richmond- Infectious Diseases
• 2013: Richmond Magazine Best Doctors in Richmond- Infectious Diseases
• 2012: Richmond Magazine Best Doctors in Richmond- Infectious Diseases
• 2011: Richmond Magazine Best Doctors in Richmond- Infectious Diseases
• 2011: Fellow of the American College of Physicians
• 2011-2012: Best Teacher Award, MII Microbiology, VCU SOM
• 2010 – 2011Academic Year in Population Medicine Course: VCU SOM High Evaluation Award Teaching Award
• 2010 – 2011 Academic Year in Microbiology Course: VCU SOM High Evaluation Award Teaching Award
• 2009 – 2010- Excellence in Research Mentorship. Division of Infectious Diseases, VCU DOIM
• 2009: Distinguished Clinical Care Faculty Award, VCU DOIM
• 2008: High Evaluation Award, M1 Population Medicine, VCU SOM
• 2008: Distinguished Clinical Care Faculty Award, VCU DOIM
• 2008: Best Teacher Award, MII Microbiology, VCU SOM
• 2007: High Evaluation Award, M1 Population Medicine, VCU SOM
• 2007: Best Teacher Award, MII Microbiology, VCU SOM
• 2006: Alpha Omega Alpha
• 2005 – 2006: Outstanding teacher Award, MII Microbiology, VCU SOM
• 2002: New York Presbyterian Hospital Housestaff/Fellowship Award
• 1997 – 1998: Intern of the Year Award, University of Buffalo
• 1993: Phi Beta Kappa - Colgate University
• 1993: Magna Cum Laude – Colgate University

Fellowships:

• Fellowships as listed above in post-doctoral training

External Grants:

• Principal Investigator. Cross-Over Trial to Determine the Efficacy of Antimicrobial Surgical Scrubs. Funding source:Vestex Technologies, $100,000. 2010-2011
• Co-Investigator. Use of sensor technology and wireless telemetry to monitor hand hygiene compliance in the inpatient setting. Funding source: BioVigil, LLC. $35,000. 2009.
• Principal Investigator. A Controlled Trial of a Universal Gloving with Neu-Thera® to Promote Skin Health, Improve Hand Hygiene and Prevent the Transmission of Multidrug-Resistant Pathogens in the ICU. Funding Source: Cardinal Healthcare. $249,000. September 2007 – September 2008.
• Principal Investigator. Risk factors and prevalence of CA MRSA nasal colonization and secondary transmission to household members in a cohort of screened patients from an ambulatory setting. Funding Source: Pfizer Pharmaceuticals. $198,000. 2006-2007.